Genome-wide association studies in developing countries raise important new ethical issues

Nov 24, 2009

Typically conducted in richer, developed countries but now increasingly done in the developing world, genome wide association (GWA) studies raise a host of ethical issues that must be addressed, argues a Policy Forum article published this week in PLoS Medicine.

Among the most pressing ethical issues is the release of data, says Michael Parker of the University of Oxford and his colleagues, who highlight the importance of developing policies and procedures for data release appropriate to GWA studies in developing countries. To highlight the practical ethical issues, they describe the development of a GWA data-release policy for the Malaria Genomic Epidemiology Network (MalariaGEN), a partnership of malaria researchers in over 20 countries supported by the Grand Challenges in Global Health initiative.

Several ethical concerns are apparent in data release of GWA studies, say the authors: privacy, whether anonymity can be guaranteed, security, the implications of collecting and storing vast amounts of data and about its uncertain future use, the implications of data release for populations, and for family members of participants, the need to strike a proper balance between research and protection, the development of appropriate governance mechanisms, the implications for trust, consent, and autonomy, commercialization, and the ethical importance of the sustainability of databases and of emerging scientific capacity in developing countries.

To address these concerns, MalariaGEN developed a "managed" approach to oversee open access, define acceptable uses of data, and guide the timing of data release.

"It is our view that an ethical data-release policy must, in addition to providing adequate protections for research participants and their communities, be combined with adequate protections for the research aspirations of developing country scientists and with capacity-building activities to ensure that those aspirations have the potential to be realized," say the authors.

More information: Parker M, Bull SJ, de Vries J, Agbenyega T, Doumbo OK, et al. (2009) Ethical Data Release in Genome-Wide Association Studies in . PLoSMed 6(11): e1000143. doi:10.1371/journal.pmed.1000143

Source: Public Library of Science (news : web)

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

Ethical implications of modifying lethal injection protocols

Jun 10, 2008

A team of medical, ethical, and legal scholars argues in this week's PLoS Medicine that in some US states the modification of lethal injection protocols is tantamount to experimentation upon prisoners without the prisoners' consen ...

Considering usual medical care in clinical trial design

Sep 29, 2009

In this week's PLoS Medicine, Liza Dawson (National Institutes of Health) and colleagues discuss the scientific and ethical issues associated with choosing clinical trial designs when there is no consensus on what consti ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.